Drug Shortage Report for MERSYNDOL WITH CODEINE

Last updated on 2022-05-02 History
Report ID 159874
Drug Identification Number 02047667
Brand name MERSYNDOL WITH CODEINE
Common or Proper name acetaminophen, codeine phosphate and doxylamine succinate
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) DOXYLAMINE SUCCINATE CODEINE PHOSPHATE ACETAMINOPHEN
Strength(s) 5MG 8MG 325MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size HDPE bottles of 100 tablets
ATC code N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-04-29
Estimated end date
Actual end date 2022-04-29
Shortage status Resolved
Updated date 2022-05-02
Company comments Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-05-02 French Compare
v7 2022-05-02 English Compare
v6 2022-05-02 English Compare
v5 2022-05-02 English Compare
v4 2022-05-02 French Compare
v3 2022-05-02 English Compare
v2 2022-05-02 English Compare
v1 2022-05-02 English Compare

Showing 1 to 8 of 8